Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its ...

A PDUFA date has been set for October 20, 2025. If approved, Epoxia will be the first epi-on corneal crosslinking on the ...

The following is a summary of “Surgical Management of Masquerading Superior Oblique Palsy,” published in the February 2025 ...

A new robotic eye surgery device developed by Moran’s Paul S. Bernstein, MD, PhD, and the University of Utah Magnetic & Medical Robotics Laboratory aims to transform retinal surgery by... John A.

1. Collagen is the 'scaffolding of our skin' Collagen is one of the main structural proteins in our body and it makes up the largest part of our 'extracellular matrix', or what Dr Wedgeworth ...

The FDA granted fast track designation to phentolamine ophthalmic solution 0.75% to treat significant chronic night driving impairment in patients who have undergone keratorefractive surgery.

On record and stage, Abba exemplified all that was fun and exhilarating in pop music. And leading the chorus in a string of worldwide hits was the distinctive, mellow voice of Frida Lyngstad, 'the ...

In this study, we analysed cases undergoing cataract surgery or refractive lens exchange surgery at the University Eye Clinic Heidelberg between January 2009 and December 2023. The study site is a ...

How do you qualify for free shipping at Collagen Co? At Collagen Co, customers are eligible for free shipping within Australia on orders of $99 or more. This offer automatically applies at ...

Becky Want with late night conversation, amazing stories and the soundtrack to your night.

The FDA granted fast track designation to phentolamine ophthalmic solution 0.75% to treat significant chronic night driving impairment in patients who have undergone keratorefractive surgery.